Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 25.69B | 27.37B | 20.91B | 20.35B | 20.90B | 21.21B |
Gross Profit | 26.61B | 0.00 | 20.91B | 20.35B | 20.90B | 21.21B |
EBITDA | -4.05B | 699.00M | -3.37B | 2.57B | 4.69B | 4.60B |
Net Income | -2.38B | 1.86B | -3.30B | 1.47B | 2.58B | 2.16B |
Balance Sheet | ||||||
Total Assets | 1.83T | 1.81T | 1.76T | 1.89T | 1.81T | 1.80T |
Cash, Cash Equivalents and Short-Term Investments | 230.62B | 0.00 | 165.70B | 248.75B | 186.75B | 216.19B |
Total Debt | 120.22B | 118.03B | 119.03B | 126.69B | 151.45B | 111.45B |
Total Liabilities | 1.75T | 1.73T | 1.68T | 176.92B | 1.73T | 1.71T |
Stockholders Equity | 75.53B | 71.65B | 78.40B | 73.67B | 81.13B | 85.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 29.22B | -144.48B | 57.40B | -1.07B | 140.68B |
Operating Cash Flow | 0.00 | 30.27B | -143.30B | 58.32B | 77.00M | 141.15B |
Investing Cash Flow | 0.00 | -3.74B | 61.00B | 4.83B | -28.35B | -20.73B |
Financing Cash Flow | 0.00 | 50.94B | -695.00M | -797.00M | -719.00M | -661.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $613.99B | 12.75 | 4.55% | 4.59% | 7.20% | 31.52% | |
72 Outperform | ¥116.84B | 7.94 | 3.98% | -12.29% | 108.55% | ||
71 Outperform | ¥185.62B | 10.15 | 3.81% | 3.28% | 7.03% | 8.58% | |
70 Outperform | $772.93B | 10.55 | 7.30% | 3.47% | 15.35% | -1.62% | |
67 Neutral | ¥722.67B | 10.84 | 7.55% | 3.29% | 7.81% | 14.63% | |
42 Neutral | ¥16.28B | 8.74 | 4.27% | -8.20% | -939.22% |